Foot and Ankle Injections: Which Conditions Might They Help—and When Might They Not?

Short answer: A foot or ankle injection may be considered when a specific joint, tendon sheath, bursa, nerve or other structure has been identified as a likely pain source. Depending on the substance and target, the aim may be temporary pain relief, reduction of inflammation, diagnostic clarification or support for rehabilitation. An injection is not a general cure for foot or ankle pain. It may be unsuitable when the diagnosis is uncertain, infection or fracture is possible, a tendon is at risk, or the main problem is mechanical instability, weakness or load intolerance.

An injection is a procedure, not a diagnosis

“Can I have an injection?” is understandable when painkillers, rest or physiotherapy have not helped. However, different pain sources require different decisions. An injection placed into an arthritic ankle joint is not equivalent to an injection around a tendon, beneath the heel, near a nerve or into a small toe joint.

Before considering a procedure, the clinician should be able to explain:

• the working diagnosis;
• the structure being targeted;
• what will be injected and why;
• whether the purpose is diagnostic, therapeutic or both;
• the expected duration and limits of benefit;
• the relevant risks and alternatives;
• what activity modification or rehabilitation is required afterwards;
• what happens if the injection does not help.

If the target cannot be defined, a scan-guided injection does not solve the diagnostic uncertainty by itself.

When foot or ankle pain needs urgent assessment instead of an injection

Seek urgent or prompt medical assessment if:

• the foot or ankle is deformed or you cannot bear weight after injury;
• pain or swelling is rapidly worsening;
• the area is hot, red and very painful, especially with fever, a wound or feeling unwell;
• the foot becomes cold, pale, blue, severely numb or suddenly weak;
• one calf becomes unexpectedly swollen or painful, particularly with chest pain or breathlessness;
• there is focal bone pain after trauma or a sudden increase in running or impact activity;
• the ankle locks, a tendon snaps out of position or the joint repeatedly gives way;
• a person with diabetes or reduced sensation develops unexplained warmth, swelling, colour change, blistering or a wound.

Injection should not delay assessment for fracture, infection, impaired circulation, blood clot, unstable injury or another urgent condition. For a life-threatening emergency in Singapore, call SCDF 995.^[1]

What should be assessed before an injection?

The history should clarify the exact pain location, onset, swelling, stiffness, trauma, locking, snapping, giving way, numbness, previous treatments and the activities that reproduce symptoms. The patient’s health conditions, allergies, medicines, pregnancy status where relevant, immune status and previous injection response may change the risk discussion.

Examination may include:

• walking pattern, foot posture and footwear;
• skin, warmth, swelling, wounds and circulation;
• precise bone, joint, tendon, ligament, fascia and nerve tenderness;
• ankle, hindfoot, midfoot and toe movement;
• ligament stability and tendon movement;
• calf, foot and toe strength;
• sensation and selected nerve-provocation tests;
• functional tasks relevant to work, walking or sport when safe.

The findings should distinguish an inflammatory target from a fracture, tendon rupture, mechanical instability, overload problem or referred pain. Injecting the most tender point without this step can expose the wrong tissue to risk and delay appropriate treatment.

When may X-ray, ultrasound, CT or MRI be considered first?

Imaging is not required before every injection, but it may be important when the diagnosis or anatomy is uncertain.

X-ray

X-rays may be used to assess arthritis, joint alignment, bone spurs, fracture or deformity. Weight-bearing views may be important for selected foot and ankle joint questions. An X-ray does not show every tendon, ligament, cartilage or nerve problem.

Ultrasound

Ultrasound can evaluate accessible tendons, tendon sheaths, bursae, plantar fascia and selected superficial masses or nerves. It can also guide a needle while avoiding nearby structures. Ultrasound does not use ionising radiation.^[2] Its usefulness depends on the clinical question and operator experience.

MRI

MRI may be considered when symptoms suggest cartilage injury, occult or stress fracture, tendon or ligament injury, deep impingement, joint inflammation, a mass or another soft-tissue problem. A scan finding must match the painful pattern; structural change on MRI does not automatically identify the correct injection target.

CT

CT may help with detailed bone, joint-surface, fracture-healing or impingement questions. It uses ionising radiation. American College of Radiology guidance for chronic foot and ankle pain selects imaging according to the suspected structure and unresolved clinical question.^[3][4]

What types of foot and ankle injections may be discussed?

Local anaesthetic injection

A local anaesthetic temporarily numbs a target. It may be combined with another medicine or used diagnostically to test whether pain is coming from a particular joint or region. A substantial, time-limited change in the patient’s usual painful activity may support the target, but the result is not infallible. Spread of anaesthetic, placebo effects, altered movement and incomplete needle placement can affect interpretation.

A diagnostic injection is most useful when the pre-injection pain can be reliably reproduced and a specific post-injection task is agreed.

Corticosteroid injection

Corticosteroid is an anti-inflammatory medicine. It may be considered for selected painful joints, bursae, tendon sheaths, synovial inflammation or impingement-related conditions. It can take several days to take effect; a temporary increase in pain can occur after injection. Benefit varies and may be temporary.^[5]

A corticosteroid injection can reduce inflammation and pain but does not correct joint alignment, rebuild cartilage, repair a ligament, restore muscle capacity or remove an unstable fragment. Repeated injections may have diminishing benefit and expose tissues to additional risk.

Platelet-rich plasma

Platelet-rich plasma, or PRP, is prepared from the patient’s blood and contains a concentrated platelet component. It is promoted for selected tendon, fascia, ligament and joint problems. Evidence varies by diagnosis, preparation method, injection technique, comparator and outcome period. “PRP” is not one standardised product, and results from one protocol do not automatically apply to another.

PRP should be discussed as one option with uncertain and condition-specific benefit, not as guaranteed tissue regeneration. Patients should ask about the exact diagnosis, evidence for that indication, cost, expected post-injection flare, rehabilitation plan and alternatives.

Hyaluronic acid

Hyaluronic acid injections are designed to supplement joint fluid and are most familiar in knee osteoarthritis care. They may be discussed for selected foot or ankle joints, but evidence and regulatory indications differ by product and joint. They do not restore normal cartilage or correct deformity. Current local availability and permissible use should be checked.

Prolotherapy

Prolotherapy commonly involves injection of an irritant solution, often dextrose-based, with the aim of stimulating a healing response. It is promoted for some ligament, tendon and joint problems, but protocols and evidence vary. It should not be assumed to tighten an unstable ankle or repair a significant tear without condition-specific evidence.

Autologous blood and other biologic injections

Autologous blood, bone-marrow-derived preparations, fat-derived products, cell-based therapies, exosomes and other regenerative approaches may be marketed for musculoskeletal conditions. These are not interchangeable. Evidence, processing, oversight and permissible claims differ substantially. Descriptions such as “stem cell” or “regenerative” do not prove that a product contains viable therapeutic cells or that it regenerates cartilage or tendon.

Some products remain experimental or may not be authorised for a proposed use in Singapore. Patients should verify what the product is, how it is regulated, what published evidence applies to their condition and whether participation is part of a registered clinical trial.

Nerve block or perineural injection

A local anaesthetic, sometimes with another medicine, may be placed near a suspected painful or entrapped nerve. This can be diagnostic, therapeutic or both. Burning, tingling and numbness do not always arise from a local foot nerve; symptoms can originate higher in the leg or spine. The neurological examination should guide the target.

Joint aspiration with or without injection

When a joint is unexpectedly hot, swollen or painful, fluid may need to be removed for analysis. This can help evaluate crystals, bleeding or infection. If infection is possible, diagnostic sampling and urgent treatment take priority; a routine steroid injection may be inappropriate.

Which foot and ankle conditions might an injection help?

When might an injection be the wrong next step?

An injection may be inappropriate or require delay when:

• the diagnosis and target are unclear;
• infection is possible or there is broken skin near the injection site;
• a fracture or stress injury has not been excluded;
• a tendon rupture, dislocation or major tear is suspected;
• mechanical instability or deformity is the main driver;
• the patient expects the procedure to replace necessary protection or rehabilitation;
• medical conditions, medicines or allergy increase procedural risk;
• previous injections gave little benefit or caused significant adverse effects;
• the proposed product lacks adequate evidence or permissible regulatory status for that use.

The American Academy of Orthopaedic Surgeons notes that corticosteroid can affect cartilage and that injection around tendinitis can increase tendon-rupture risk, particularly around the Achilles tendon.^[5] The exact risk depends on the tissue, medicine, dose, technique and patient.

What are the possible risks?

Risks differ by injectate and target. They can include:

• pain during the procedure or a temporary post-injection flare;
• bruising or bleeding;
• infection;
• allergic or vasovagal reaction;
• skin thinning, pigment change or fat atrophy with corticosteroid;
• temporary rise in blood glucose after corticosteroid;
• nerve or blood-vessel injury;
• tendon weakening or rupture;
• plantar-fascia rupture or heel-fat-pad damage;
• cartilage effects with repeated corticosteroid exposure;
• failure to reach the target or failure to improve pain;
• delay in diagnosing or treating the true problem.

Patients should receive instructions on expected soreness, activity after the procedure and symptoms requiring urgent review. Increasing heat, redness, swelling, fever, discharge, severe pain, numbness or colour change after injection requires prompt medical assessment.

Does ultrasound guidance make an injection better?

Ultrasound guidance allows the clinician to view the needle, target and some nearby structures in real time. It can be useful for small joints, tendon sheaths, bursae, cysts and areas close to nerves or vessels. AAOS notes that guidance can reduce the risk of missing a joint space.^[5]

Accuracy is not the same as effectiveness. A precisely placed injection into the wrong pain source may still fail. Image guidance also does not remove risks from the medicine or make an unsuitable indication appropriate.

What happens after an injection?

Post-procedure advice depends on the target and substance. There may be a short period of relative rest followed by gradual return to activity. The patient should know when to resume work, driving, walking, exercise and sport. A temporary reduction in pain should not be used to test the foot with sudden high load before the treated tissue is ready.

The injection should be part of a plan that may include footwear changes, load management, bracing, medication review and rehabilitation. Progress should be measured against the original goal, such as morning-step pain, walking duration, swelling, work tolerance, strength or return to sport.

Which approach fits the patient’s situation?

“I need fast relief because I must return to work next week”

A targeted injection may provide relief for selected inflammatory joint or soft-tissue conditions, but the response and duration cannot be guaranteed. First establish whether weight bearing is safe. A fracture, significant tendon injury or unstable ankle may need protection even if an injection could temporarily reduce pain. Work modifications, footwear or bracing may be safer short-term tools.

“I have already tried physiotherapy and exercises”

Review the diagnosis, the type and progression of rehabilitation, and whether symptoms changed. An injection may help a defined pain source that prevents rehabilitation, but it should not be the automatic next step. Persistent bone pain, locking, snapping or instability may require imaging or referral rather than symptom suppression.

“I do not want exercises and prefer a passive treatment”

Your preference should be part of shared decision-making. An injection may reduce symptoms from a suitable target, but it cannot restore strength, balance or load tolerance. A small, focused rehabilitation plan may still be necessary to make the benefit useful and reduce recurrence.

“I want PRP because it is natural”

PRP is derived from the patient’s blood, but that does not mean it is risk-free or effective for every condition. Ask whether evidence applies to your exact diagnosis, how the product is prepared, how many procedures are proposed, what rehabilitation follows and what happens if it does not work.

“I want steroid because it worked before”

Previous benefit is relevant, but repeated injections require review of cumulative risk, duration of benefit and whether the diagnosis has changed. Shortening relief may indicate diminishing value. A new injury, infection, fracture or tendon problem should be excluded.

“My scan shows several abnormalities—which one should be injected?”

The target should match the pain location, examination and activity pattern. A diagnostic anaesthetic injection may sometimes help localise symptoms, but it is not conclusive in every case. Treating every scan abnormality is neither necessary nor safe.

“I am afraid of needles”

Tell the clinician before the procedure. Ask about positioning, local anaesthetic, image guidance, what sensations to expect and whether a non-injection alternative is reasonable. An injection should not proceed without informed consent.

Questions to ask before agreeing to an injection

• What is my diagnosis and which structure will be injected?
• Is the purpose diagnosis, temporary relief or longer-term improvement?
• Why this substance rather than another option?
• What evidence applies to this specific condition?
• Will ultrasound or another form of guidance be used, and why?
• What are the risks for my medical history and medicines?
• How soon can I work, walk, drive or exercise?
• What rehabilitation or load modification is needed?
• When will the outcome be reviewed?
• What is the alternative if I decline or if it does not help?

Integrated doctor and physiotherapy management

The Pain Relief Clinic has in-house physiotherapists who can work with the licensed medical doctor for integrated management. Where an injection is clinically appropriate and available, this can help coordinate the diagnosis, imaging decision, pre-procedure functional baseline, post-procedure load advice and rehabilitation.

Integrated care may be particularly useful when pain has prevented exercise or when temporary symptom relief is intended to create an opportunity for graded rehabilitation. Physiotherapists practising in Singapore should be appropriately registered.^[6]

Insurance referrals and supporting paperwork

The clinic can assist with clinically appropriate referrals and supporting paperwork for insurance claims. Coverage, required documents, pre-authorisation and reimbursement depend on the patient’s policy and insurer. A referral, form or medical report does not guarantee approval or payment.

Before imaging, injection or physiotherapy, patients may wish to confirm whether their insurer requires a doctor’s referral, panel provider, pre-authorisation, procedure code, itemised invoice, imaging report or medical report.

Frequently asked questions

What is the best injection for foot or ankle pain?

There is no single best injection. The appropriate option depends on the diagnosis, target, evidence, risks, previous care and patient goals. Some pain should not be injected.

How long does a steroid injection last?

Duration varies. Some patients receive little benefit, while others obtain relief for weeks or longer. It does not cure the underlying cause of many conditions, and repeated injections may become less effective.^[5]

Can steroid be injected into the Achilles tendon?

Corticosteroid around tendinopathy can increase tendon-rupture risk, and the Achilles requires particular caution.^[5] Injection into the tendon itself is generally avoided. The diagnosis, target and alternatives should be carefully reviewed.

Is PRP proven for plantar fasciitis or Achilles tendinopathy?

Research findings vary by condition and protocol. PRP may be discussed for selected chronic problems, but benefit is not guaranteed and it does not replace diagnosis, load management or rehabilitation.

Is an ultrasound-guided injection painless?

No. Guidance can improve visualisation and placement but does not make the procedure completely painless. Local anaesthetic and technique may reduce discomfort.

Can I walk immediately after a foot injection?

Advice depends on the target and injectate. Some patients may walk with short-term modification; others require greater protection. Follow the specific post-procedure instructions rather than assuming reduced pain means unrestricted activity is safe.

How many injections can I have?

There is no universal number across all substances and conditions. The decision depends on tissue, medicine, dose, response, interval, cumulative risk and alternatives. Repeated procedures without meaningful or durable benefit should trigger reassessment.

Arrange a foot or ankle pain assessment in Singapore

If foot or ankle pain has persisted despite medication, footwear changes or physiotherapy, an assessment can reconsider the diagnosis and whether imaging, revised rehabilitation, an injection or specialist referral may be appropriate. Not every patient needs or is suitable for an injection.

The Pain Relief Clinic
350 Orchard Road, #10-00 Shaw House
Singapore 238868
Telephone: +65 9068 9605

Not every investigation or treatment discussed on this page is required, offered or recommended by the clinic. Availability and permissible use of tests, medicines, devices, injections, biologic products and emerging treatments in Singapore may change with evolving Ministry of Health, Health Sciences Authority and Singapore Medical Council requirements. HSA regulates medical devices and therapeutic products in Singapore; product status and permitted use should be checked using current information.^[7] Individual decisions require clinical assessment and should follow current Singapore regulations and professional guidance.

References

1. Singapore Civil Defence Force. Emergency Medical Services.
2. National Institute of Biomedical Imaging and Bioengineering. Ultrasound.
3. American College of Radiology. ACR Appropriateness Criteria: Chronic Ankle Pain.
4. American College of Radiology. ACR Appropriateness Criteria: Chronic Foot Pain.
5. American Academy of Orthopaedic Surgeons. Cortisone Shot (Steroid Injection).
6. Allied Health Professions Council Singapore. Search the register.
7. Health Sciences Authority Singapore. Medical devices.

Disclaimer: This information is provided for general reference only and should be used in consultation with your licensed medical doctor. It is not a diagnosis or a substitute for personalised medical advice. Seek urgent care for severe, rapidly worsening or warning-feature symptoms.

Reviewed by Dr Terence Tan — 13 September 2026